article thumbnail

Johnson & Johnson’s big bet on intelligent automation

CIO

Three years ago, Johnson & Johnson (J&J) set out to apply intelligent automation (IA) to every aspect of its business. By combining RPA with machine learning (ML) and artificial intelligence (AI), they sought to automate more complex tasks. The team has already nearly hit that mark.

article thumbnail

The ‘Great Retraining’: IT upskills for the future

CIO

When the timing was right, Chavarin honed her skills to do training and coaching work and eventually got her first taste of technology as a member of Synchrony’s intelligent virtual assistant (IVA) team, writing human responses to the text-based questions posed to chatbots.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Statistics for the Outsourcing of Market and Competitive Intelligence Activities

Cipher

In partnership with Forrester Research , Cipher conducted a study in March 2021 exploring how life science companies and third-party market and competitive intelligence (M/CI) vendors can best work together.

article thumbnail

5 steps to better pharmaceutical competitive intelligence - InfoDesk

WideNARROW

In today’s highly competitive and rapidly advancing pharmaceutical industry, a well-oiled competitive intelligence process is essential in order to drive business success.

article thumbnail

How Nvidia became a trillion-dollar company

CIO

Nvidia’s transformation from an accelerator of video games to an enabler of artificial intelligence (AI) and the industrial metaverse didn’t happen overnight—but the leap in its stock market value to over a trillion dollars did. Nvidia says its hardware, software, and services can cut early-stage drug discovery from months to weeks.

article thumbnail

Generative AI usage gains traction among enterprises: McKinsey

CIO

Artificial Intelligence, Enterprise Applications, Generative AI In contrast, manufacturing-based industries, such as aerospace, automotive, and advanced electronics could experience less disruptive effects due to limitations of the new technology’s usage in these industries as most work requires physical labor, the report said.

article thumbnail

U.S. Pharmaceutical Industry Seen to Focus on COVID-19 Treatments Amid Competitive Environment

ArchIntel

pharmaceutical industry in 2021 and beyond. The race to create new products against COVID-19 amid the emergence of new mutations is expected to eclipse every other effort in health care and pharmaceuticals this year. pharmaceutical and health care industry’s more notable CI executives. ArchIntel™ -.